🇺🇸 FDA
Pipeline program

filgrastim

SJMB03

Phase 3 mab completed

Quick answer

filgrastim for Brain and Central Nervous System Tumors is a Phase 3 program (mab) at Hospital Authority, Hong Kong with 2 ClinicalTrials.gov record(s).

Program details

Company
Hospital Authority, Hong Kong
Indication
Brain and Central Nervous System Tumors
Phase
Phase 3
Modality
mab
Status
completed

Clinical trials